Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of …
$101.59+0.34%
报价 2026-11-13
市值
$6.64B
EV
$5.34B
PE (TTM)
21.3x
预期 PE (FY2026)
18.6x
52 周区间距高点 -8.4%
$52.50$110.94
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 6.36 → 6.66(1.0x) | 15.2 |
| FY+32028-12 | 1.2x | 6.36 → 8.67(1.4x) | 11.7 |
毛利率 61% · TTM 收入 $1562M · 基数 EPS 6.36(调整后)
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| LNTHLantheus Holdings, Inc. | $6.64B | +0.3% | -0.5% | 61.1% | 21.3x | 13.2x | 16.9x | |
| HNGEHinge Health, Inc. | $9.38B | -4.6% | +53.6% | 87% | 58.5x | 58.7x | 30.8x | 高增长 |
| PRAXPraxis Precision Medicines, Inc. | $9.17B | +1.0% | +133.3% | 0% | – | – | – | |
| AMRXAmneal Pharmaceuticals, Inc. | $7.45B | -1.5% | +6.6% | 42% | 41.2x | 14.1x | 78.8x | |
| ACADACADIA Pharmaceuticals Inc. | $3.24B | +3.4% | +18.4% | 90.5% | 8.6x | 19.5x | 28.4x | |
| BHCBausch Health Companies Inc. | $3.13B | +1.2% | +6.8% | 75% | – | 8.9x | 1.7x | |
| ADMAADMA Biologics, Inc. | $3.03B | +3.3% | +4.7% | 68.5% | 16.7x | 12.0x | 22.3x | |
| HCMHutchison China Ltd. | $2.6B | +0.3% | +12.2% | 17% | 145.0x | – | 234.4x | |
| SUPNSupernus Pharmaceuticals, Inc. | $1.73B | +1.8% | +26.8% | 85.7% | 8.0x | 3.4x | 55.3x | Cheap GARP |
| 同行中位数 | – | – | +15.3% | 71.8% | 29.0x | 13.1x | 30.8x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。